These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31010466)

  • 1. Multipotent Mesenchymal Stromal Cells for Pulmonary Fibrosis?
    Purdon S; Patete CL; Glassberg MK
    Am J Med Sci; 2019 May; 357(5):390-393. PubMed ID: 31010466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of mesenchymal stem cells in the treatment of idiopathic pulmonary fibrosis].
    Zhang J; Shao CZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jul; 43(7):595-598. PubMed ID: 32629562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell and Idiopathic Pulmonary Fibrosis: Mechanisms and Treatment.
    Liu M; Ren D; Wu D; Zheng J; Tu W
    Curr Stem Cell Res Ther; 2015; 10(6):466-76. PubMed ID: 25986617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
    Glassberg MK; Minkiewicz J; Toonkel RL; Simonet ES; Rubio GA; DiFede D; Shafazand S; Khan A; Pujol MV; LaRussa VF; Lancaster LH; Rosen GD; Fishman J; Mageto YN; Mendizabal A; Hare JM
    Chest; 2017 May; 151(5):971-981. PubMed ID: 27890713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving stem cell therapy to patients with idiopathic pulmonary fibrosis.
    Glassberg MK; Toonkel RL
    Respirology; 2014 Oct; 19(7):950-1. PubMed ID: 25124287
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesenchymal stem cell treatment for IPF-time for phase 2 trials?
    Antoniou KM; Karagiannis K; Tsitoura E; Tzanakis N
    Lancet Respir Med; 2017 Jun; 5(6):472-473. PubMed ID: 28664848
    [No Abstract]   [Full Text] [Related]  

  • 7. Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.
    Barczyk M; Schmidt M; Mattoli S
    Stem Cell Rev Rep; 2015 Aug; 11(4):598-620. PubMed ID: 25896401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis.
    Chambers DC; Enever D; Ilic N; Sparks L; Whitelaw K; Ayres J; Yerkovich ST; Khalil D; Atkinson KM; Hopkins PM
    Respirology; 2014 Oct; 19(7):1013-8. PubMed ID: 25039426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steep barriers to overcome for successful application of stem cell treatment in patients with idiopathic pulmonary fibrosis.
    Tzouvelekis A; Bouros D
    Am J Respir Crit Care Med; 2013 Jul; 188(2):251-2. PubMed ID: 23855695
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research and Application of Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis: A Review].
    Feng XR; Yao J; Wu Y; Cheng X; Zou PJ; Wang H; Yang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):373-379. PubMed ID: 34018353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.
    Toonkel RL; Hare JM; Matthay MA; Glassberg MK
    Am J Respir Crit Care Med; 2013 Jul; 188(2):133-40. PubMed ID: 23306542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis: Well Done, but Subsequent Doses May Be Vital.
    Thangakunam B; Christopher DJ
    Chest; 2018 Jan; 153(1):287. PubMed ID: 29307425
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
    Ghadiri M; Young PM; Traini D
    Expert Opin Biol Ther; 2016; 16(3):375-87. PubMed ID: 26593230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mesenchymal stem cells and idiopathic pulmonary fibrosis].
    Niu H; Xu WJ; Zhu XP
    Zhonghua Jie He He Hu Xi Za Zhi; 2021 Sep; 44(9):844-847. PubMed ID: 34496528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of IV Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis.
    Limper AH
    Chest; 2017 May; 151(5):951-952. PubMed ID: 28483127
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach.
    Chambers DC; Hopkins PM
    Am J Respir Crit Care Med; 2013 Jul; 188(2):252-3. PubMed ID: 23855696
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell therapy trials for lung diseases: progress and cautions.
    Weiss DJ; Ortiz LA
    Am J Respir Crit Care Med; 2013 Jul; 188(2):123-5. PubMed ID: 23855686
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply: idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach.
    Glassberg MK; Hare JM; Toonkel RL; Matthay MA
    Am J Respir Crit Care Med; 2013 Jul; 188(2):253-4. PubMed ID: 23855697
    [No Abstract]   [Full Text] [Related]  

  • 19. Expanding autologous multipotent mesenchymal bone marrow stromal cells.
    Brinchmann JE
    J Neurol Sci; 2008 Feb; 265(1-2):127-30. PubMed ID: 17560612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.
    Cahill EF; Kennelly H; Carty F; Mahon BP; English K
    Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.